The majority of patients affected by RTT carry mutations in their MECP2 (methyl-CpG-binding-protein-2) gene [3], which is located on the long arm of the X-chromosome and encodes the transcriptional modulator MeCP2. Here, MECP2 is linked to Rett syndrome.